Axsome Therapeutics

AXSMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.948 B

$212.74 +1.24%

Close of 7 Aug 2026

Revenue

$638.5M

#1791 by revenue

Earnings

-$183.2M

Loss-making

Shares outstanding

51,459,766

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#33Summit TherapeuticsSMMT$11.1B
#34Elanco Animal HealthELAN$11.1B
#35Axsome TherapeuticsAXSM$10.9B
#36Dr Reddys LaboratoriesRDY$10.2B
#37Praxis Precision MedicinesPRAX$10.1B

Where these numbers come from

Share counts and financials for Axsome Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.